Last reviewed · How we verify

vinorelbine plus oxaliplatin

Fudan University · Phase 2 active Small molecule Quality 0/100

vinorelbine plus oxaliplatin is a Small molecule drug developed by Fudan University. It is currently in Phase 2 development.

At a glance

Generic namevinorelbine plus oxaliplatin
SponsorFudan University
ModalitySmall molecule
PhasePhase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about vinorelbine plus oxaliplatin

What is vinorelbine plus oxaliplatin?

vinorelbine plus oxaliplatin is a Small molecule drug developed by Fudan University.

Who makes vinorelbine plus oxaliplatin?

vinorelbine plus oxaliplatin is developed by Fudan University (see full Fudan University pipeline at /company/fudan-university).

What development phase is vinorelbine plus oxaliplatin in?

vinorelbine plus oxaliplatin is in Phase 2.

Related